Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 May;71(5):1114–1123. doi: 10.1172/JCI110861

Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate.

C B Brendler, S J Berry, L L Ewing, A R McCullough, R C Cochran, J D Strandberg, B R Zirkin, D S Coffey, L G Wheaton, M L Hiler, M J Bordy, G D Niswender, W W Scott, P C Walsh
PMCID: PMC436972  PMID: 6189857

Abstract

This paper is a cross-sectional study of spontaneous benign prostatic hyperplasia (BPH) in a single canine species. The effects of aging and hormonal changes on the growth, histology, and glandular secretory function of the canine prostate were studied in 42 male beagles ranging in age from 8 mo to 9 yr. The beagle prostate enlarges for at least 6 yr, whether normal or hyperplastic. In contrast, prostatic secretory function, determined by ejaculate volume and total ejaculate protein, declines markedly after 4 yr of age. These reciprocal growth and functional changes in the prostate are closely associated with a progressive increase in the incidence of BPH, which is already apparent in some dogs by age two. With age there is a modest decrease in serum androgen levels with no apparent change in serum 17 beta-estradiol levels. This suggests that the growth and functional changes that are associated with the development of BPH and are initiated very early in life reflect an altered sensitivity of the prostate to serum androgens or a response to the relative decrease in the serum androgen to estrogen ratio.

Full text

PDF
1114

Images in this article

1116Image
on p.1116
1116Image
on p.1116
1117Image
on p.1117
1117Image
on p.1117
1120Image
on p.1120

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert J., Geller J., Geller S., Lopez D. Prostate concentrations of endogenous androgens by radioimmunoassay. J Steroid Biochem. 1976 Apr;7(4):301–307. doi: 10.1016/0022-4731(76)90131-x. [DOI] [PubMed] [Google Scholar]
  2. BERG O. A. Parenchymatous hypertrophy of the canine prostate gland. Acta Endocrinol (Copenh) 1958 Feb;27(2):140–154. doi: 10.1530/acta.0.0270140. [DOI] [PubMed] [Google Scholar]
  3. Cochran R. C., Ewing L. L., Niswender G. D. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia. Invest Urol. 1981 Nov;19(3):142–147. [PubMed] [Google Scholar]
  4. DeKlerk D. P., Coffey D. S., Ewing L. L., McDermott I. R., Reiner W. G., Robinson C. H., Scott W. W., Strandberg J. D., Talalay P., Walsh P. C. Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest. 1979 Sep;64(3):842–849. doi: 10.1172/JCI109532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Geller J., Albert J., Lopez D., Geller S., Niwayama G. Comparison of androgen metabolites in benign prostatic hypertrophy (BPH) and normal prostate. J Clin Endocrinol Metab. 1976 Sep;43(3):686–688. doi: 10.1210/jcem-43-3-686. [DOI] [PubMed] [Google Scholar]
  6. Gloyna R. E., Siiteri P. K., Wilson J. D. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog. J Clin Invest. 1970 Sep;49(9):1746–1753. doi: 10.1172/JCI106392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HUGGINS C., SOMMER J. L. Quantitative studies of prostatic secretion. III. Simultaneous measurement of size and secretion of the canine prostate and the interaction of androgenic and estrogenic substances thereon. J Exp Med. 1953 May;97(5):663–680. doi: 10.1084/jem.97.5.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hammond G. L. Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues. J Endocrinol. 1978 Jul;78(1):7–19. doi: 10.1677/joe.0.0780007. [DOI] [PubMed] [Google Scholar]
  9. Harbitz T. B., Haugen O. A. Histology of the prostate in elderly men. A study in an autopsy series. Acta Pathol Microbiol Scand A. 1972;80(6):756–768. doi: 10.1111/j.1699-0463.1972.tb00347.x. [DOI] [PubMed] [Google Scholar]
  10. Isaacs J. T., Coffey D. S. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia. Endocrinology. 1981 Feb;108(2):445–453. doi: 10.1210/endo-108-2-445. [DOI] [PubMed] [Google Scholar]
  11. Isaacs J. T., Isaacs W. B., Wheaton L. G., Coffey D. S. Differential effects of estrogen treatment on canine seminal plasma components. Invest Urol. 1980 May;17(6):495–498. [PubMed] [Google Scholar]
  12. Jacobi G. H., Moore R. J., Wilson J. D. Studies on the mechanism of 3 alpha-androstanediol-induced growth of the dog prostate. Endocrinology. 1978 Jun;102(6):1748–1758. doi: 10.1210/endo-102-6-1748. [DOI] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Lloyd J. W., Thomas J. A., Mawhinney M. G. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy. Invest Urol. 1975 Nov;13(3):220–222. [PubMed] [Google Scholar]
  15. McNeal J. E. Origin and evolution of benign prostatic enlargement. Invest Urol. 1978 Jan;15(4):340–345. [PubMed] [Google Scholar]
  16. Nawata H., Kato K., Ibayashi H. Age-dependent change of serum 5alpha-dihydrotestosterone and its relation to testosterone in man. Endocrinol Jpn. 1977 Feb;24(1):41–45. doi: 10.1507/endocrj1954.24.41. [DOI] [PubMed] [Google Scholar]
  17. O'SHEA J. D. Studies on the canine prostate gland. I. Factors influencing its size and weight. J Comp Pathol. 1962 Jul;72:321–331. doi: 10.1016/s0368-1742(62)80037-x. [DOI] [PubMed] [Google Scholar]
  18. Ofner P. Effects and metabolism of hormones in normal and neoplastic prostate tissue. Vitam Horm. 1968;26:237–291. doi: 10.1016/s0083-6729(08)60756-6. [DOI] [PubMed] [Google Scholar]
  19. Pirke K. M., Doerr P. Age related changes in free plasma testosterone, dihydrotestosterone and oestradiol. Acta Endocrinol (Copenh) 1975 Sep;80(1):171–178. doi: 10.1530/acta.0.0800171. [DOI] [PubMed] [Google Scholar]
  20. Shain S. A., Nitchuk W. M. Testosterone metabolism by the prostate of the aging canine. Mech Ageing Dev. 1979 Aug;11(1):23–35. doi: 10.1016/0047-6374(79)90061-7. [DOI] [PubMed] [Google Scholar]
  21. Siiteri P. K., Wilson J. D. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man. J Clin Invest. 1970 Sep;49(9):1737–1745. doi: 10.1172/JCI106391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sköldefors H., Blomstedt B., Carlström K. Serum hormone levels in benign prostatic hyperplasia. Scand J Urol Nephrol. 1978;12(2):111–114. doi: 10.3109/00365597809179975. [DOI] [PubMed] [Google Scholar]
  23. Vermeulen A., Rubens R., Verdonck L. Testosterone secretion and metabolism in male senescence. J Clin Endocrinol Metab. 1972 Apr;34(4):730–735. doi: 10.1210/jcem-34-4-730. [DOI] [PubMed] [Google Scholar]
  24. Walsh P. C., Wilson J. D. The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest. 1976 Apr;57(4):1093–1097. doi: 10.1172/JCI108353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wheaton L. G., de Klerk D. P., Strandberg J. D., Coffey D. S. Relationship of seminal volume to size and disease of the prostate in the beagle. Am J Vet Res. 1979 Sep;40(9):1325–1328. [PubMed] [Google Scholar]
  26. Wilson J. D. The pathogenesis of benign prostatic hyperplasia. Am J Med. 1980 May;68(5):745–756. doi: 10.1016/0002-9343(80)90267-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES